SCHEMBL24650613

SCHEMBL24650613

CC[C@@H]1CNCc2ncc3ccccc3c2O1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALPG P10696 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTR1A P08908 1/20 0.33
HTR7 P34969 1/20 0.33
HTR2B P41595 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
SSTR4 P31391 2/20 0.31
NFKB1 P19838 2/20 0.31
NFKB2 Q00653 2/20 0.31
RELA Q04206 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GPR3 P46089 1/20 0.31
LMNA P02545 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24650207 1.00 CYP1A2 (0.36) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
SCHEMBL22744293 1.00 CYP1A2 (0.36) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
Hydrochloric Acid SCHEMBL29442749 0.99 CYP1A2 (0.36) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
Hydrochloric Acid SCHEMBL29442631 0.99 CYP1A2 (0.36) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
SCHEMBL22744271 0.83 KDM4E (0.33) KDM4EGPR3LMNAHPGD
SCHEMBL24650471 0.77 NFKB1 (0.45) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
SCHEMBL29442713 0.77 NFKB1 (0.45) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
SCHEMBL24650011 0.74 CYP1A2 (0.36) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
SCHEMBL29442644 0.74 CYP1A2 (0.36) CYP1A2CYP2D6ALPGCYP2C19SMN1; SMN2
SCHEMBL24650610 0.74 CYP1A2 (0.34) CYP1A2KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220259223-A1 BENZOTRIAZOLE DERIVATIVE UBE INDUSTRIES, LTD. (JP) 2022-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220259223-A1 BENZOTRIAZOLE DERIVATIVE KEAP1, NFE2L2, BACH1 CYP1A2 622/4885CYP2D6 1142/4885ALPG 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.